(Q35169759)

6 August 2017

1 reference

title

Radionuclide imaging technologies and their use in evaluating asthma drug deposition in the lungs (English)

1 reference

6 August 2017

1 reference

1 reference

Stephen P Newman

1

1 reference

6 August 2017

Gary R Pitcairn

series ordinal

2

1 reference

6 August 2017

Peter H Hirst

series ordinal

3

1 reference

6 August 2017

Lisa Rankin

series ordinal

4

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Advanced Drug Delivery Reviews

6 August 2017

published in

1 reference

6 August 2017

volume

55

1 reference

6 August 2017

issue

7

1 reference

6 August 2017

page(s)

851-867

1 reference

Determining equivalence of inhaled medications. Consensus statement from a workshop of the British Association for Lung Research, held at Royal Brompton National Heart & Lung Institute, London 24 June 1994.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Comparison of the extrapulmonary beta2-adrenoceptor responses and pharmacokinetics of salbutamol given by standard metered dose-inhaler and modified actuator device

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Methods used to assess pulmonary deposition and absorption of drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

A method for determination of the absolute pulmonary bioavailability of inhaled drugs: terbutaline

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Determination of the relative bioavailability of salbutamol to the lung following inhalation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Mathematical model for the selective deposition of inhaled pharmaceuticals.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Regional deposition of inhaled hygroscopic aerosols: in vivo SPECT compared with mathematical modeling.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

The efficacy of slow versus faster inhalation of cromolyn sodium in protecting against allergen challenge in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Use of spacers to facilitate inhaled corticosteroid treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Airway deposition and airway effects of antiasthma drugs delivered from metered-dose inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

1 reference

7 January 2021

Method for monitoring hard gelatin capsule disintegration times in humans using external scintigraphy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

In vivo evaluation of dosage forms: application of gamma scintigraphy to non-enteral routes of administration

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Gamma scintigraphy in the evaluation of pharmaceutical dosage forms

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Radionuclide scanning, respiratory physiology, and pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Alpha-1-antitrypsin labeling with technetium-99m for monitoring the deposition of alpha-1-antitrypsin in aerosol therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Pulmonary drug delivery from the Taifun dry powder inhaler is relatively independent of the patient's inspiratory effort

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

New method for easy labeling of beta-2-agonists in the metered dose inhaler with technetium 99m

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Pressurised aerosol deposition in the human lung with and without an "open" spacer device

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Deposition of pressurised aerosols in the human respiratory tract

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Deposition of fenoterol from pressurized metered dose inhalers containing hydrofluoroalkanes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

The physico-chemical basis of radiolabelling metered dose inhalers with 99mTc

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Assessing lung deposition of inhaled medications. Consensus statement from a workshop of the British Association for Lung Research, held at the Institute of Biology, London, U.K. on 17 April 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

The effect of scatter and attenuation on aerosol deposition as determined by gamma scintigraphy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Accounting for radioactivity before and after nebulization of tobramycin to insure accuracy of quantification of lung deposition

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Pulmonary clearance rate of two chemically different forms of inhaled pertechnetate

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Comparison of gamma scintigraphy and a pharmacokinetic technique for assessing pulmonary deposition of terbutaline sulphate delivered by pressurized metered dose inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Evaluation of the accuracy and precision of lung aerosol deposition measurements from single-photon emission computed tomography using simulation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

A brief history of gamma scintigraphy.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Use of single photon emission computed tomography in aerosol studies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Assessment of deposition of inhaled aerosol in the respiratory tract of man using three-dimensional multimodality imaging and mathematical modeling.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Three-Dimensional imaging of aerosol deposition

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Aerosol deposition and clearance measurement: a novel technique using dynamic SPET.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

A new method of quantification of the pulmonary regional distribution of aerosols using combined CT and SPECT and its application to nedocromil sodium administered by metered dose inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

The pulmonary deposition of two aerosol preparations of nedocromil sodium delivered by MDI assessed by single photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Comparisons of planar and tomographic gamma scintigraphy to measure the penetration index of inhaled aerosols

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

In vivo pharmacokinetics and pharmacodynamics in drug development using positron-emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Deposition and clearance of inhaled 18FDG powder in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Measuring total and regional lung deposition using inhaled radiotracers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Regional distribution and kinetics of inhaled pharmaceuticals

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Imaging techniques for assessing drug delivery in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

What is the nature of asthma and where are the therapeutic targets?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Therapeutic aerosols in children

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Technegas--a new ventilation agent for lung scanning

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Effect of add-on devices for aerosol drug delivery: deposition studies and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

New guidelines on asthma management

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Evolution of dry powder inhaler design, formulation, and performance

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Efficient delivery to the lungs of flunisolide aerosol from a new portable hand-held multidose nebulizer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Lung deposition of fenoterol and flunisolide delivered using a novel device for inhaled medicines: comparison of RESPIMAT with conventional metered-dose inhalers with and without spacer devices

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Deposition and pharmacokinetics of an HFA formulation of triamcinolone acetonide delivered by pressurized metered dose inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

The pharmacokinetics of inhaled hydrofluoroalkane formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Human lung deposition data: the bridge between in vitro and clinical evaluations for inhaled drug products?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Scintigraphic comparison of budesonide deposition from two dry powder inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

Lung deposition of budesonide from the novel dry powder inhaler Airmax

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900081-4

7 January 2021

10.1016/S0169-409X(03)00081-4

Identifiers

DOI

1 reference

6 August 2017

1 reference